{"id":"W3087988414","doi":"10.1016/j.annonc.2020.08.952","title":"813MO Efficacy of subsequent chemotherapy for patients with BRCA1/2 mutated platinum-sensitive recurrent epithelial ovarian cancer (EOC) progressing on olaparib vs placebo: The SOLO2/ENGOT Ov-21 trial","year":2020,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Olaparib; Chemotherapy; Internal medicine; Placebo; Progression-free survival; Oncology; Ovarian cancer; Gastroenterology; Surgery; Cancer; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005973986,0.0009061404,0.001827384,0.0002727658,0.0002745115,0.000850879,0.0004722855,0.001238461,0.006941987],"category_scores_gemma":[0.0008424818,0.000331747,0.002051712,0.0002855982,0.0005433832,0.0007435197,0.0003037511,0.002613069,0.0008585394],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005069975,"about_ca_system_score_gemma":0.0005086658,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006075458,"about_ca_topic_score_gemma":0.001756278,"domain_scores_codex":[0.9997695,0.0001077636,0.00001261894,0.0000470929,0.00001620909,0.0000467918],"domain_scores_gemma":[0.9996393,0.0001039943,0.00007519416,0.00003548264,0.00001557547,0.0001304458],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9002922,0.004120864,0.002581767,0.001092032,0.002217666,0.00009527433,0.0000712227,0.001151899,0.004976588,0.0003230903,0.002462951,0.08061445],"study_design_scores_gemma":[0.8410272,0.1337806,0.01536757,0.0002055965,0.002153009,0.0001862783,0.00007279086,0.001189106,0.001346217,0.0007793573,0.003852653,0.00003965221],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9788521,0.01136147,0.0002689553,0.001304361,0.0005413273,0.0005854462,0.001363309,0.000108029,0.005615081],"genre_scores_gemma":[0.9872729,0.004096284,0.0003465371,0.001227888,0.0003280656,0.0003837228,0.001622746,0.00002244112,0.004699395],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006941987,"threshold_uncertainty_score":0.02322322,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09531459648497898,"score_gpt":0.3987324027835507,"score_spread":0.3034178062985717,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}